rs79736124

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006158.5(NEFL):​c.*1100C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0384 in 152,618 control chromosomes in the GnomAD database, including 155 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.038 ( 155 hom., cov: 32)
Exomes 𝑓: 0.079 ( 0 hom. )

Consequence

NEFL
NM_006158.5 3_prime_UTR

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.43
Variant links:
Genes affected
NEFL (HGNC:7739): (neurofilament light chain) Neurofilaments are type IV intermediate filament heteropolymers composed of light, medium, and heavy chains. Neurofilaments comprise the axoskeleton and they functionally maintain the neuronal caliber. They may also play a role in intracellular transport to axons and dendrites. This gene encodes the light chain neurofilament protein. Mutations in this gene cause Charcot-Marie-Tooth disease types 1F (CMT1F) and 2E (CMT2E), disorders of the peripheral nervous system that are characterized by distinct neuropathies. A pseudogene has been identified on chromosome Y. [provided by RefSeq, Oct 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 8-24951710-G-A is Benign according to our data. Variant chr8-24951710-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 362628.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-24951710-G-A is described in Lovd as [Likely_benign].
BA1
GnomAdExome4 highest population allele frequency = 0.0787 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NEFLNM_006158.5 linkc.*1100C>T 3_prime_UTR_variant Exon 4 of 4 ENST00000610854.2 NP_006149.2 P07196

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NEFLENST00000610854.2 linkc.*1100C>T 3_prime_UTR_variant Exon 4 of 4 1 NM_006158.5 ENSP00000482169.2 P07196

Frequencies

GnomAD3 genomes
AF:
0.0383
AC:
5821
AN:
152068
Hom.:
155
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0236
Gnomad AMI
AF:
0.0965
Gnomad AMR
AF:
0.0366
Gnomad ASJ
AF:
0.0565
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.00954
Gnomad FIN
AF:
0.0965
Gnomad MID
AF:
0.0791
Gnomad NFE
AF:
0.0410
Gnomad OTH
AF:
0.0540
GnomAD4 exome
AF:
0.0787
AC:
34
AN:
432
Hom.:
0
Cov.:
0
AF XY:
0.0885
AC XY:
23
AN XY:
260
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.0798
AC:
34
AN:
426
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
2
Other (OTH)
AF:
0.00
AC:
0
AN:
4
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.0383
AC:
5824
AN:
152186
Hom.:
155
Cov.:
32
AF XY:
0.0392
AC XY:
2918
AN XY:
74404
show subpopulations
African (AFR)
AF:
0.0237
AC:
983
AN:
41526
American (AMR)
AF:
0.0366
AC:
559
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.0565
AC:
196
AN:
3466
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5178
South Asian (SAS)
AF:
0.00954
AC:
46
AN:
4820
European-Finnish (FIN)
AF:
0.0965
AC:
1021
AN:
10582
Middle Eastern (MID)
AF:
0.0816
AC:
24
AN:
294
European-Non Finnish (NFE)
AF:
0.0411
AC:
2792
AN:
68008
Other (OTH)
AF:
0.0535
AC:
113
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
290
580
871
1161
1451
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
66
132
198
264
330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0391
Hom.:
173
Bravo
AF:
0.0341
Asia WGS
AF:
0.00433
AC:
15
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Charcot-Marie-Tooth disease, type I Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
5.7
DANN
Benign
0.55
PhyloP100
1.4

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs79736124; hg19: chr8-24809223; API